B
GSK icon

Baird’s GSK GSK Stock Holding History

Baird’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$12.2M Sell
211,990
-1,348
-0.6% -$77.3K 0.13% 191
2014
Q4 		$11.4M Buy
213,338
+167,410
+365% +$9.37M 0.12% 200
2014
Q3 		$2.64M Buy
45,928
+3,660
+9% +$224K 0.04% 396
2014
Q2 		$2.83M Buy
42,268
+848
+2% +$57.4K 0.04% 394
2014
Q1 		$2.77M Buy
41,420
+602
+1% +$40.7K 0.04% 398
2013
Q4 		$2.72M Buy
40,818
+9,230
+29% +$598K 0.05% 394
2013
Q3 		$1.98M Sell
31,588
-3,208
-9% -$207K 0.04% 444
2013
Q2 		$2.17M Buy
+34,796
New +$2.21M 0.04% 400

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baird's GSK Position: Q1 2015 in Review

Baird reduced its GSK (GSK) stake by 0.63% in Q1 2015, selling an estimated $77.3K and leaving 211,990 shares worth $12.2M. The position accounts for 0.13% of the portfolio, ranked #191.

Baird first reported a position in GSK in Q2 2013 and has held it in 8 quarters since. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • Baird held 211,990 shares of GSK worth $12.2M as of Q1 2015.
  • Baird sold 1,348 GSK shares in Q1 2015, an estimated $77.3K.
  • GSK made up 0.13% of Baird's portfolio in Q1 2015, its #191 holding.
  • Baird first reported a position in GSK in Q2 2013 and has held it in 8 quarters since.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.